Pear Therapeutics PEAR Stock
Pear Therapeutics Price Chart
Pear Therapeutics PEAR Financial and Trading Overview
| Pear Therapeutics stock price | 0.03 USD |
| Previous Close | 0.03 USD |
| Open | 0.04 USD |
| Bid | 0 USD x 3100 |
| Ask | 0 USD x 1400 |
| Day's Range | 0.03 - 0.04 USD |
| 52 Week Range | 0.009 - 6.74 USD |
| Volume | 66.3M USD |
| Avg. Volume | 10.09M USD |
| Market Cap | 4.17M USD |
| Beta (5Y Monthly) | 0.519904 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.33 USD |
PEAR Valuation Measures
| Enterprise Value | -17497016 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.064888895 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.32834244 |
| Price/Book (mrq) | 0.13394496 |
| Enterprise Value/Revenue | -1.378 |
| Enterprise Value/EBITDA | 0.152 |
Trading Information
Pear Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.519904 |
| 52-Week Change | -99.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.74 USD |
| 52 Week Low | 0.009 USD |
| 50-Day Moving Average | 0.43 USD |
| 200-Day Moving Average | 1.43 USD |
PEAR Share Statistics
| Avg. Volume (3 month) | 10.09M USD |
| Avg. Daily Volume (10-Days) | 16.35M USD |
| Shares Outstanding | 140.03M |
| Float | 54.43M |
| Short Ratio | 2.33 |
| % Held by Insiders | 16.52% |
| % Held by Institutions | 59.54% |
| Shares Short | 3.43M |
| Short % of Float | 4.62% |
| Short % of Shares Outstanding | 2.39% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -938.17% |
| Gross Margin | 41.75% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.93% |
| Return on Equity (ttm) | -124.75% |
Income Statement
| Revenue (ttm) | 12.69M USD |
| Revenue Per Share (ttm) | 0.09 USD |
| Quarterly Revenue Growth (yoy) | 94.29% |
| Gross Profit (ttm) | 5.3M USD |
| EBITDA | -115125000 USD |
| Net Income Avi to Common (ttm) | -75491000 USD |
| Diluted EPS (ttm) | -0.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 59.27M USD |
| Total Cash Per Share (mrq) | 0.42 USD |
| Total Debt (mrq) | 37.61M USD |
| Total Debt/Equity (mrq) | 122.96 USD |
| Current Ratio (mrq) | 1.476 |
| Book Value Per Share (mrq) | 0.218 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -113895000 USD |
| Levered Free Cash Flow (ttm) | -64181624 USD |
Profile of Pear Therapeutics
| Country | United States |
| State | MA |
| City | Boston |
| Address | 200 State Street |
| ZIP | 02109 |
| Phone | 617 925 7848 |
| Website | https://peartherapeutics.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 200 |
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastroenterology, cardiology, and oncology. Pear Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. On April 7, 2023, Pear Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Q&A For Pear Therapeutics Stock
What is a current PEAR stock price?
Pear Therapeutics PEAR stock price today per share is 0.03 USD.
How to purchase Pear Therapeutics stock?
You can buy PEAR shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pear Therapeutics?
The stock symbol or ticker of Pear Therapeutics is PEAR.
Which industry does the Pear Therapeutics company belong to?
The Pear Therapeutics industry is Health Information Services.
How many shares does Pear Therapeutics have in circulation?
The max supply of Pear Therapeutics shares is 142.74M.
What is Pear Therapeutics Price to Earnings Ratio (PE Ratio)?
Pear Therapeutics PE Ratio is 0.00000000 now.
What was Pear Therapeutics earnings per share over the trailing 12 months (TTM)?
Pear Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Pear Therapeutics company belong to?
The Pear Therapeutics sector is Healthcare.
Pear Therapeutics PEAR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}